Femasys Inc (FEMY) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Femasys Inc   (NASDAQ: FEMY)


Femasys Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FEMY Gross Profit Margin (Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2
Y / Y Revenue Change -18.92 %
Seq. Revenue Change -21.9 %
Revenue In Millions $0.33
Gross Profit Margin 57.08 %
Gross Profit Margin Total Ranking # 1277
Gross Profit In Millions $0.19
Y / Y Gross Profit Change -24.57 %
Seq. Gross Profit Change -28.88 %


Commenting Second Quarter 2026 Gross Profit Margin
Femasys Inc experienced contraction in Gross Profit by -28.88 % to $0 millions and Revenue by -21.9 %, while Gross Profit Margin fell to 57.08 % a new company low.


Observing second quarter 2026 results within Medical Equipment & Supplies industry 86 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 1277.
Learn about Gross Margin
FEMY's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 87
Healthcare Sector # 235
Overall # 1266

Gross Profit Margin Statistics
High Average Low
74.71 % 65.23 % 57.08 %
(Dec 31 2021)   (Jun 30 2026)


FEMY Gross Income Trends • More of FEMY's Profitabilty Ratios • FEMY Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
FEMY's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
FEMY's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for FEMY's Competitors
Gross Profit Margin Profit Margin for Femasys Inc 's Suppliers
Gross Profit Margin Profit Margin for FEMY's Customers

You may also want to know
FEMY's Annual Growth Rates FEMY's Profitability Ratios FEMY's Asset Turnover Ratio FEMY's Dividend Growth
FEMY's Roe FEMY's Valuation Ratios FEMY's Financial Strength Ratios FEMY's Gross Profit Growth
FEMY's Roa FEMY's Inventory Turnover Ratio FEMY's Growth Rates FEMY's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Agape Atp Corporation  98.24 %$ 0.107  Millions$ 0.109  Millions
Invo Fertility Inc   97.24 %$ 2.115  Millions$ 2.175  Millions
Sanara Medtech Inc   92.96 %$ 26.155  Millions$ 28.137  Millions
Ceribell Inc   92.32 %$ 25.938  Millions$ 28.097  Millions
Sight Sciences Inc   91.39 %$ 21.374  Millions$ 23.388  Millions
Seastar Medical Holding Corp  91.22 %$ 0.561  Millions$ 0.615  Millions
Delcath Systems Inc   89.75 %$ 26.148  Millions$ 29.133  Millions
Cvrx inc   87.39 %$ 13.724  Millions$ 15.705  Millions
Trisalus Life Sciences Inc   86.78 %$ 9.899  Millions$ 11.407  Millions
Electrocore Inc   86.53 %$ 8.177  Millions$ 9.450  Millions
Sharps Technology Inc   86.06 %$ 1.755  Millions$ 2.039  Millions
Neuraxis Inc   85.87 %$ 1.656  Millions$ 1.929  Millions
Inspire Medical Systems inc   85.48 %$ 171.459  Millions$ 200.581  Millions
Mobia Medical Inc   83.21 %$ 11.238  Millions$ 13.505  Millions
Heartflow Inc   83.00 %$ 53.190  Millions$ 64.082  Millions
Neuropace Inc   82.83 %$ 18.906  Millions$ 22.826  Millions
Vycor Medical Inc   82.35 %$ 0.344  Millions$ 0.418  Millions
Avita Medical Inc   81.87 %$ 17.767  Millions$ 21.702  Millions
Glaukos Corp  81.67 %$ 151.594  Millions$ 185.610  Millions
Si bone inc   79.54 %$ 44.548  Millions$ 56.010  Millions
Vaso Corporation  79.46 %$ 8.889  Millions$ 11.187  Millions
Electromed Inc   78.71 %$ 15.284  Millions$ 19.417  Millions
Treace Medical Concepts Inc   78.47 %$ 35.607  Millions$ 45.376  Millions
Profound Medical Corp   78.41 %$ 1.947  Millions$ 2.483  Millions
Pulmonx Corporation  77.97 %$ 17.742  Millions$ 22.756  Millions
Novocure Limited  77.61 %$ 142.478  Millions$ 183.584  Millions
Edwards Lifesciences Corporation  77.46 %$ 1,348.600  Millions$ 1,741.000  Millions
Atricure Inc   77.23 %$ 118.629  Millions$ 153.604  Millions
Anteris Technologies Global Corp   76.91 %$ 0.776  Millions$ 1.009  Millions
Carlsmed Inc   76.78 %$ 14.542  Millions$ 18.940  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.